A comparative study between efficacy of topical JAK inhibitor alone versus JAK inhibitor with phototherapy in vitiligo patients
Not Applicable
- Conditions
- Health Condition 1: L80- Vitiligo
- Registration Number
- CTRI/2024/07/070001
- Lead Sponsor
- Dr Sneha Ulhaskumar Arakeri
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients of vitiligo with = 2 depigmented patches (not on the mucosa) each =10% BSA
Exclusion Criteria
Patients with mucosal lesions
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method to compare improvement in the pigmentation status in both armsTimepoint: at 4 weeks, 8weeks and 12 weeks
- Secondary Outcome Measures
Name Time Method to assess the re-pigmentation in the tofacitinib armTimepoint: at 12 weeks